FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies Save Peptides Save Peptides On July 23 and July 23, 2026 from 8:00 am to 4:30 pm EST, the Food and Drug Administration, HHS, will be holding a public advisory meeting of the Pharmacy Compounding Advisory Committee in Silver FDA Removes 12 Peptides from 503A Category 2 : r us_pharmacies FDA July 2026 Peptide Meeting: What Patients Need to Know About Access, Approval, and Safety Meto blog